Journey Medical Corporation
DERM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$14,672 | -$3,853 | -$29,628 | -$43,994 |
| Dep. & Amort. | $3,424 | $3,855 | $4,365 | $2,560 |
| Deferred Tax | $0 | $0 | $0 | $1,566 |
| Stock-Based Comp. | $6,098 | $2,606 | $4,425 | $2,466 |
| Change in WC | -$3,766 | -$1,655 | $6,187 | $14,709 |
| Other Non-Cash | -$211 | $4,287 | $1,117 | $20,512 |
| Operating Cash Flow | -$9,127 | $5,240 | -$13,534 | -$2,181 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$15,000 | -$5,000 | -$20,000 | -$10,000 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$15,000 | -$5,000 | -$20,000 | -$10,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $8,700 | -$8,948 | $16,899 | $5,052 |
| Stock Issued | $8,293 | $4,494 | $142 | $32,536 |
| Stock Repurch. | $0 | $0 | -$371 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$350 | -$214 | $16,971 |
| Financing Cash Flow | $16,993 | -$4,804 | $16,456 | $53,016 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$7,134 | -$4,564 | -$17,078 | $40,835 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $27,439 | $32,003 | $49,081 | $8,246 |
| End Cash | $20,305 | $27,439 | $32,003 | $49,081 |
| Free Cash Flow | -$9,127 | $240 | -$33,534 | -$12,181 |